Stockscreener 앱 받기
22.57
1.61%
-0.37
시간 외 거래:
22.57
전일 마감가:
$22.94
열려 있는:
$22.65
하루 거래량:
667.90K
Relative Volume:
0.63
시가총액:
$1.29B
수익:
$2.25B
순이익/손실:
$-1.18B
주가수익비율:
-1.0907
EPS:
-20.6926
순현금흐름:
$19.92M
1주 성능:
-3.51%
1개월 성능:
+1.21%
6개월 성능:
-30.25%
1년 성능:
-42.76%
1일 변동 폭
$22.15
$23.22
1주일 범위
$22.15
$24.44
52주 변동 폭
$21.00
$40.70
Enovis Corp Stock (ENOV) Company Profile
명칭
Enovis Corp
전화
(302) 252-9160
주소
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
22.57 | 1.31B | 2.25B | -1.18B | 19.92M | -20.69 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 개시 | BTIG Research | Buy |
| 2024-10-03 | 개시 | JMP Securities | Mkt Outperform |
| 2024-06-13 | 개시 | JP Morgan | Neutral |
| 2024-02-13 | 개시 | Stephens | Overweight |
| 2024-01-22 | 개시 | UBS | Buy |
| 2024-01-03 | 개시 | William Blair | Outperform |
| 2023-12-15 | 재확인 | Needham | Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-06-26 | 개시 | Needham | Buy |
| 2023-05-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-11 | 개시 | Goldman | Buy |
| 2022-09-12 | 개시 | Canaccord Genuity | Buy |
| 2022-09-12 | 개시 | Evercore ISI | Outperform |
| 2022-06-28 | 개시 | Argus | Hold |
| 2022-06-27 | 재개 | Loop Capital | Buy |
| 2022-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Enovis Corp 주식(ENOV)의 최신 뉴스
Tranche Update on Enovis Corporation's Equity Buyback Plan announced on February 16, 2018. - marketscreener.com
Enovis (NYSE:ENOV) Rating Increased to Strong-Buy at Wells Fargo & Company - MarketBeat
Enovis Corporation (NYSE:ENOV) Q4 2025 earnings call transcript - MSN
UBS reiterates Enovis stock Buy rating on growth outlook - Investing.com
UBS reiterates Enovis stock Buy rating on growth outlook By Investing.com - Investing.com UK
Enovis (ENOV) to report earnings tomorrow: Here is what to expect - MSN
Wells Fargo Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $42 - 富途牛牛
Signal Recap: Can Enovis Corporation maintain its current growth rate2026 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn
Insider Buying: Oliver Engert Acquires Shares of Enovis Corp (EN - GuruFocus
Oliver Engert Buys 1,000 Shares of Enovis (NYSE:ENOV) Stock - MarketBeat
Engert Oliver, chief administrative officer, buys Enovis Corp (ENOV) shares - Investing.com
Enovis tops profit expectations but revenue falls short - MSN
[Form 4] Enovis CORP Insider Trading Activity - Stock Titan
Invenomic Capital Management LP Has $21.62 Million Holdings in Enovis Corporation $ENOV - MarketBeat
ENOV SEC FilingsEnovis Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Enovis Corporation $ENOV Stake Lowered by Dorsey Asset Management LLC - MarketBeat
How The Enovis (ENOV) Story Is Shifting Around Growth Margins And Cash Generation - Yahoo Finance
Enovis (NYSE:ENOV) Stock Rating Upgraded by Wall Street Zen - MarketBeat
ESAB,ENOV Options - Finviz
Enovis Corporation (ENOV): Orthopedic innovation and growth potential drive analyst confidence - MSN
Top Enovis Insider Makes Bold Move With Fresh Stock Purchase - TipRanks
Engert Oliver, chief administrative officer at Enovis, buys $23,930 in ENOV - Investing.com South Africa
Enovis (ENOV) CAO Oliver Engert buys 1,000 shares in open-market trade - Stock Titan
Barclays PLC Lowers Stake in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Is Down 5.5% After 2025 Loss And 2026 Revenue Outlook UpdateHas The Bull Case Changed? - simplywall.st
Enovis (NYSE:ENOV) Insider Oliver Engert Purchases 750 Shares - MarketBeat
Enovis (ENOV) CFO awarded 47,974 RSUs as 3,167 shares withheld for taxes - Stock Titan
Enovis (ENOV) CAO Oliver Engert adds 1,750 shares in open-market buys - Stock Titan
Enovis (ENOV) exec Louis Vogt awarded 36,247 RSUs; 1,980 shares withheld for taxes - Stock Titan
Unveiling Q4 Financial Results: How Enovis (NYSE:ENOV) Compares With Other Specialty Medical Devices & Supplies Stocks - Bitget
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & SuppliesSpecialty Stocks - Yahoo Finance
A Look At Enovis (ENOV) Valuation After 2025 Earnings Losses And 2026 Revenue Guidance - simplywall.st
Enovis Outperforms Rennova Health in Key Financial Metrics - National Today
One Fund Bet $5 Million on Enovis Stock Last Quarter. Shares Surged 14% Post-Earnings - AOL.com
Aug Macro: Can Enovis Corporation ride the EV waveStop Loss & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Enovis (ENOV) CFO logs 2,220-share tax withholding, holds 113,789 shares - Stock Titan
Enovis (ENOV) HR chief has 1,173 RSU shares withheld to cover taxes - Stock Titan
Zacks Research Upgrades Enovis (NYSE:ENOV) to Strong-Buy - MarketBeat
Enovis (ENOV) Q4 earnings beat estimates - MSN
Enovis (ENOV) Group President has 765 shares withheld for taxes on RSUs - Stock Titan
Insider Buying: Enovis (NYSE:ENOV) Insider Buys 1,000 Shares of Stock - MarketBeat
Insider Buying: Oliver Engert Acquires Additional Shares of Enovis Corp (ENOV) - GuruFocus
Enovis (ENOV) CAO adds 1,250 shares in two open-market buys - Stock Titan
Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet - Finviz
Why Enovis (ENOV) Is Up 10.5% After 2025 Losses And 2026 Growth Guidance - simplywall.st
Enovis at 2026 CG Musculoskeletal Conference: Strategic Growth and Innovation - Investing.com
ENOV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Enovis (NYSE:ENOV) Insider Purchases $25,500.00 in Stock - MarketBeat
Enovis (ENOV) executive has 418 shares withheld for RSU tax obligations - Stock Titan
Enovis (ENOV) CFO records 720-share tax withholding transaction - Stock Titan
Enovis Corporation (ENOV): Investor Outlook On A Promising 75.8% Potential Upside - DirectorsTalk Interviews
Enovis Corp (ENOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):